26 September 2013
410
Deer B., MMR doctor Andrew Wakefield fixed data on autism, The Sunday Times, 8 February 2009
411
Horton R. The lessons of MMR. Lancet. 2004; 363 (9411): 747–9
412
Miriam Falco, Vaccine study's author held related patent, medical journal reports, CNN, January 12, 2011
413
RETRACTED: Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998; 351(9103): 637–41
414
Flaherty DK. The vaccine-autism connection: a public health crisis caused by unethical medical practices and fraudulent science. Ann Pharmacother. 2011; 45(10): 1302–4
415
Health and Social Care Information Centre, NHS Immunisation Statistics England 2012–13, 26, September 2013.
416
Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014; 32(29): 3623–9.
417
Seida JK, Ospina MB, Karkhaneh M, Hartling L, Smith V, Clark B. Systematic reviews of psychosocial interventions for autism: an umbrella review. Dev Med Child Neurol. 2009; 51(2): 95–104
418
Eikeseth S. Outcome of comprehensive psycho-educational interventions for young children with autism. Res Dev Disabil. 2009; 30(1): 158–78.
419
https://pubmed.ncbi.nlm.nih.gov/28110691.
420
https://pubmed.ncbi.nlm.nih.gov/26503762/.
421
https://molecularautism.biomedcentral.com/articles/10.1186/s13229–020–0313–1.
422
Buitelaar JK. Why have drug treatments been so disappointing?. Novartis Found Symp. 2003; 251: 235–44
423
Nicholas Lofthouse, Robert Hendren, Elizabeth Hurt, L. Eugene Arnold, and Eric Butter, "A Review of Complementary and Alternative Treatments for Autism Spectrum Disorders," Autism Research and Treatment, vol. 2012, 2012
424
Tonya N. Davis et al., "Chelation Treatment for Autism Spectrum Disorders: A Systematic Review," Research in Autism Spectrum Disorders 7 (January 2013): 49–55
425
Tonya N. Davis et al., "Chelation Treatment for Autism Spectrum Disorders: A Systematic Review," Research in Autism Spectrum Disorders 7 (January 2013): 49–55
426
Myles, B. S., Huggins, A., Rome-Lake, M., Hagiwara, T., Barnhill, G. P., & Griswold, D. E. (2003). Written Language Profile of Children and Youth with Asperger Syndrome: From Research to Practice. Education and Training in Developmental Disabilities, 38(4), 362–369
427
Blume H., Autistics, freed from face-to-face encounters, are communicating in cyberspace. The New York Times, June 30, 1997
428
Saner E., 'It is not a disease, it is a way of life', The Guardian, 7 August 2007
429
https://www.autismspeaks.org/liub.
430
General Assembly resolution 62/139, World Autism Awareness Day, A/RES/62/139 (21 January 2008), available from undocs.org/A/RES/62/139.
431
Morel BA. Traité des maladies mentales. [Treatise on mental diseases]. Paris, France: Masson; 1860
432
Berrios GE. Phthisical insanity by T. S. Clouston. Hist Psychiatry. 2005; 16(Pt 4 (no 64)): 473–9
433
Hecker E. Die Hebephrenie: ein Beitrag zur klinischen Psychiatrie. [Hebephrenia: a contribution to clinical psychiatry] Archiv für pathologische Anatomie und für klinische Medizin. 1871
434
Kahlbaum KL. Die Gruppierung der psychischen Krankheiten und die Einteilung der Seelenstörungen. [The Grouping of Psychiatric Diseases and the Classification of Mental Disturbances]. Danzig, Germany: Kafemann; 1863
435
Kraepelin E. Psychiatrie. 6 Auflage. Leipzig, Austria: Barth 1899. English translation by Metoui H, Ayed S: Psychiatry, A Textbook for Students and Physicians
436
Waters FA, Badcock JC, Dragovic´ M, Jablensky A. Neuropsychological functioning in schizophrenia patients with first-rank (passivity) symptoms. Psychopathology. 2009; 42(1): 47–58
437
Wilkinson G. Political dissent and "sluggish" schizophrenia in the Soviet Union. British Medical Journal (Clinical research ed). 1986; 293(6548): 641–642
438
Bonnie RJ. Political abuse of psychiatry in the Soviet Union and in China: complexities and controversies. J Am Acad Psychiatry Law. 2002; 30(1): 136–44
439
World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization
440
Liddle PF. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry. 1987; 151: 145–51
441
Johnstone EC, Frith CD. Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patients. Psychol Med. 1996; 26(4): 669–79
442
Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry. 1995; 52(5): 352–60
443
World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization
444
F. Waters, C. Fernyhough. Hallucinations: A Systematic Review of Points of Similarity and Difference Across Diagnostic Classes. Schizophrenia Bulletin, Volume 43, Issue 1, 1 January 2017, Pages 32–43.
445
Lindström, E et al., The ICD-10 and DSM – IV diagnostic criteria and the prevalence of schizophrenia, European Psychiatry, (1997). Volume 12, Issue 5, 217–223
446
Upthegrove R, Birchwood M, Ross K, Brunett K, Mccollum R, Jones L. The evolution of depression and suicidality in first episode psychosis. Acta Psychiatr Scand. 2010; 122(3): 211–8
447
Sham PC, Maclean CJ, Kendler KS. A typological model of schizophrenia based on age at onset,
